Psychiatry

Top Story

Neurocrine presents Ingrezza efficacy, safety data for tardive dyskinesia

April 27, 2017

At the American Academy of Neurology annual meeting, researchers presented long-term efficacy and safety data supporting the recent FDA approval of Ingrezza for tardive dyskinesia in adults.

“We are very pleased to present additional robust data from the largest ever clinical program in tardive dyskinesia at this year’s American Academy of Neurology Annual Meeting,” Chris O'Brien, MD, FAAN, chief medical officer at Neurocrine, said in a press release. “Over 1,000 persons have participated in more than 20 Ingrezza clinical trials, with consistent and strong results demonstrated by the first and only FDA-approved treatment for adults with tardive dyskinesia. These expanded safety, efficacy and pharmacologic findings continue to illustrate Ingrezza’s differentiated potential and what it offers to an underserved community.”

Meeting News

Severe Impairment Battery effective for Alzheimer's disease

April 27, 2017
Findings presented at the American Academy of Neurology showed accuracy of quantitatively-derived Severe Impairment Battery composite scores for individuals with…
In the Journals

Sibling death in childhood may increase risk for early mortality

April 26, 2017
An individual whose sibling dies during childhood has an increased risk for short-term and long-term mortality, according to results of a population-based study. The…
In the Journals

Medical marijuana laws influence increases in cannabis use, disorder

April 26, 2017
States that passed medical marijuana laws experienced greater increases in illicit cannabis use and cannabis use disorder than states that did not pass such laws…
More News Headlines »
Original ResearchOpen Access

Validating Health Literacy and Numeracy Measures in Minority Groups

HLRP: Health Literacy Research and Practice, Spring 2017, Volume 1 Issue 2
Validation studies of existing health literacy or numeracy tools among racial/ethnic minorities are limited. This study…
More »
CME

Overview of Consultation-Liaison Psychiatry: April 2017

Keck School of Medicine of USC and Psychiatric Annals

There is no health without psychiatric health. Psychiatric disorders are not only highly prevalent, but they are even…
More »
Featured
U.S. Psychiatric & Mental Health Congress

U.S. Psychiatric & Mental Health Congress

Video
Meeting News

VIDEO: Behavioral interventions, medication-assisted treatment key to treating opioid addiction

October 23, 2016
More »
Advertisement
Advertisement